enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. New Urine Test for Prostate Cancer May Help Reduce ... - AOL

   www.aol.com/lifestyle/urine-test-prostate-cancer...

   A prostate cancer biomarker test that utilizes 17 genetic markers has demonstrated a high degree of accuracy in screening for serious cancer. The test also significantly reduced unnecessary ...

3. New prostate cancer imaging shows ‘extremely encouraging ...

   www.aol.com/prostate-cancer-imaging-shows...

   Prostate cancer imaging developed by university researchers has shown “extremely encouraging” results in its first clinical trials. A team at Heriot-Watt University, Edinburgh, leading the ...

4. Prostate cancer screening - Wikipedia

   en.wikipedia.org/wiki/Prostate_cancer_screening

   Prostate cancer screening is the screening process used to detect undiagnosed prostate cancer in men without signs or symptoms. [1] [2] When abnormal prostate tissue or cancer is found early, it may be easier to treat and cure, but it is unclear if early detection reduces mortality rates.

5. Targeted screening for prostate cancer ‘could prevent up to ...

   www.aol.com/targeted-screening-prostate-cancer...

   A screening programme targeted at men who are genetically predisposed to prostate cancer, and involving a blood test and MRI scan before an invasive biopsy, could prevent one in six prostate ...

6. Kevin Slawin - Wikipedia

   en.wikipedia.org/wiki/Kevin_Slawin

   Slawin is a co-discoverer of -2proPSA (P2PSA), [8] [9] a molecular form of prostate specific antigen, which has been shown to improve the accuracy of prostate cancer screening. [10] A multi-center study supported by the National Cancer Institute verified the ability of proPSA to be a valid marker for early detection of prostate cancer. [11]

7. Richard J. Ablin - Wikipedia

   en.wikipedia.org/wiki/Richard_J._Ablin

   Richard J. Ablin (May 15, 1940 – October 6, 2023) [1] was an American scientist, most notable for research on prostate cancer.According to the Wall Street Journal: . Richard Ablin, a professor of pathology at University of Arizona College of Medicine, discovered the prostate-specific antigen (PSA) in 1970, and for nearly as long, he has argued that it should not be used for routine screening.